Pacira Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Pacira Biosciences Inc inventory turnover ratio, the Pacira Biosciences Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.04 in the second quarter 2026, yet the ratio remained below the average, as PCRX's market remain challenging.Average inventory processing period, for the Pacira Biosciences Inc in Jun 30 2026 quarter, has decreased to 351 days, compare to 365 days, in the Mar 31 2026 quarter.

Within Healthcare sector 307 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 658 in the first quarter 2026, to 1797.

PCRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pacira Biosciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PCRX Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-9.17 %	12.42 %	22.02 %	40.96 %	43.24 %
Y / Y Cost of Sales Growth	8.07 %	6.14 %	1.04 %	-11.8 %	-7.67 %
Inventory Turnover Ratio (TTM)	1.04	1	1.01	1.06	1.19
PCRX's Total Ranking	# 1797	# 658	# 1291	# 1139	# 1359
Average inventory processing period	350	366	361	345	308
Seq. Inventory Growth	-10.5 %	-1.63 %	-3.05 %	6.42 %	10.77 %
Seq. Cost of Sales Growth	21.29 %	-9.64 %	17.57 %	-16.12 %	19.12 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 90
Healthcare Sector	# 308
Overall Market	# 1797

Inventory Turnover Ratio Statistics
High	Average	Low
6.21	2.37	0.97
(Dec 31 2014)		(Dec 31 2025)

PCRX Company Profile >> Back to PCRX Efficiency Comparisons >> Compare PCRX Inventory Turnover Ratio to its Competitors

Financial Statements
Pacira Biosciences Inc 's Inventories	$ 135 Millions	Visit PCRX's Balance sheet
Pacira Biosciences Inc 's Cost of Revenues TTM	$ 155 Millions	Visit PCRX's Income Statement
What are PCRX's Sales?		Visit PCRX's Sales by Segment

Other Inventory Turnover Ratios
Pacira Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PCRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PCRX's Competitors
Inventory Turnover Ratio for PCRX's Suppliers
Inventory Turnover Ratio for PCRX's Customers

You may also want to know
PCRX's Sales Growth Rates	PCRX's Pe Price to earnings ratio	PCRX's Receivables Turnover Ratio	PCRX's Stock Quote
PCRX's Net Income Growth Rates	PCRX's Ps Price to Sales ratio	PCRX's Sales per Employee	PCRX's Asset Turnover Ratio
PCRX's Net Margin	PCRX's Pb Price to Book ratio	PCRX's Financial Strength Ratios	PCRX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions
Embecta Corp	2.19	$ 418.400 Millions	$ 191 Millions
Avita Medical Inc	2.18	$ 13.950 Millions	$ 6 Millions
Johnson and Johnson	2.17	$ 31,428.000 Millions	$ 14,516 Millions
Anika Therapeutics Inc	2.14	$ 46.366 Millions	$ 22 Millions
Bio techne Corp	2.10	$ 414.798 Millions	$ 197 Millions
Yunhong Green Cti Ltd	2.09	$ 17.362 Millions	$ 8 Millions

Date modified: 2026-08-31T11:29:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.